Recurrent strongyloides stercoralis infection as a sentinel symptom of HTLV-1-infection;Rezidivierende strongyloidose als indikator einer HTLV-1-infektion

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 16, 2005, Pages 1007-1010

  Richter, Pisa Joachim ^a,d   Schwarz, U ^b   Duwe, S ^c   Ellerbrok, H ^c   Poggensee, G ^c   Pauli, G ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Tropeninstitut Berlin ^*  (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d Tropenmedizinische Ambulanz   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IVERMECTIN;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG TOLERABILITY; FEVER; GUINEA; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTE COUNT; MALE; MUSCLE STIFFNESS; NECK MUSCLE; NUCLEOTIDE SEQUENCE; ORTHOPEDIC SURGERY; PHYLOGENY; POLYMERASE CHAIN REACTION; PRURITUS; RECURRENT INFECTION; SERODIAGNOSIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; VIRUS TRANSMISSION;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; FECES; FEVER; GERMANY; GUINEA; HEADACHE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; NECK PAIN; PARASITE EGG COUNT; PHYLOGENY; PRURITUS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TRAVEL;

EID: 17844386803     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-866778     Document Type: Article

References (20)

1. Adedayo AO, Grell GA, Bellot P. Case study: Fatal strongyloides associated with human T-cell lymphotrophic virus type 1-infection. Am J Trop Med Hyg 2001; 65: 650-651
2. Araújo A, Hall W. Human T-lymphotropic virus type II and neurological disease. Ann Neurol 2004; 56: 10-19
3. Burger R, Gerlich W, Gürtler L et al. Human T-Cell Lymphotropic Viruses Type 1 and 2 (HTLV-I/II). Infusionsther Transfusionsmed 1999; 26: 321-326
4. Ellerbrok H, Fleischer C, Vandamme AM, Kucherer C, Pauli G. Sequence analysis of two HTLV type I infections imported to Germany. AIDS Res Hum Retroviruses 1997; 13: 1255-1258
5. Flaig MJ, Rommel F, Campe H, Emmerich B, Sander CA. Das adulte T-Zell Lymphom/Leukämie - eine in Europa sehr seltene Erkrankung. Dtsch Med Wochenschr 2001; 126: 389
6. Gentilini M. Laboratoire en zone tropicale: Formule sanguine. 10th ed (Hrsg). Flammarion Paris, In: Gentilini M., Médicine Tropicale. 1996: 753
7. Gill GV, Beeching NJ, Khoo S et al. A British Second World War veteran with disseminated strongyloidiasis. Trans R Soc Trop Med Hyg 2004; 98: 382-386
8. Guzzo CA, Furtek CI, Porras AG et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 2002; 42: 1122-1133
9. Kamgno J, Gardon J, Gardon-Wendel N, Demanga-Ngangue B, Duke BO, Boussinesq D. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly. Trans R Soc Trop Med Hyg 2004; 98: 496-504
10. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17: 208-217
11. Marti HP, Haji HJ, Savioli L et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for the treatment of Strongyloides stercoralis infection. Am J Trop Med Hyg 1996; 55: 477
12. Mravak S, Schopp W, Bienzle U. Treatment of strongyloidiasis with mebendazole. Acta Trop 1983; 40: 93-94
13. Orland JR, Engstrom J, Fridey J et al., for the HTLV Outcomes Study Group. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 2003; 61: 1588-1594
14. Poiesz BJ, Poiesz MJ, Choi D. The human T-cell lymphoma/leukemia viruses. Cancer Invest 2003; 21: 253-277
15. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980; 77: 7415-7419
16. Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcantara L, Carvalho EM. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001; 23: 503-507
17. Remberger K, Pahl S. Fallbeispiel: Tödliche hämorrhagische Pneumonie durch Strongyloides stercoralis-Hyperinfektion. Epidemiol Bull RKI 1996; 40: 275
18. III. Shelburne S, Shandera WX. Infections: viral and rickettsial: Human T Cell Lymphotropic Virus (HTLV). 43rd ed (Hrsg). Lange; McGraw Hill; New York, In: Tierney LM, McPhee SJ, Papadakis MA edts. Current Medical Diagnosis and Treatment. 2004: 1316-1317
19. Sugiyama H, Doi H, Yamaguchi K, Tsuji Y, Miyamoto T, Hino S. Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-1 on the development of adult T-cell Leukemia/ lymphoma. J Med Virol 1986; 20: 253-260
20. Vrielink H, Reesink HW. HTLV-I/II prevalence in different geographic locations. Transfus Med Rev 2004; 18: 46-57